Agenus Inc AGEN:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 06/28/22 EDT
1.84quote price arrow up+1.84 (UNCH)
Volume
16,126
Close
1.84quote price arrow down-0.04 (-2.13%)
Volume
4,137,428
52 week range
1.25 - 6.79
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close1.84
  • 52 Week High6.79
  • 52 Week High Date08/30/21
  • 52 Week Low1.25
  • 52 Week Low Date06/14/22

Key Stats

  • Market Cap497.30M
  • Shares Out270.27M
  • 10 Day Average Volume6.00M
  • Dividend-
  • Dividend Yield-
  • Beta1.16
  • YTD % Change-42.86

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close1.84
  • 52 Week High6.79
  • 52 Week High Date08/30/21
  • 52 Week Low1.25
  • 52 Week Low Date06/14/22
  • Market Cap497.30M
  • Shares Out270.27M
  • 10 Day Average Volume6.00M
  • Dividend-
  • Dividend Yield-
  • Beta1.16
  • YTD % Change-42.86

RATIOS/PROFITABILITY

  • EPS (TTM)-0.10
  • P/E (TTM)-19.19
  • Fwd P/E (NTM)-2.06
  • EBITDA (TTM)50.365M
  • ROE (TTM)-421.78%
  • Revenue (TTM)309.89M
  • Gross Margin (TTM)99.06%
  • Net Margin (TTM)-8.04%
  • Debt To Equity (MRQ)90.22%

EVENTS

  • Earnings Date08/08/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Agenus Inc

There is no recent news for this security.

Content From Our Affiliates

Profile

MORE
Agenus Inc. is a clinical-stage immuno-oncology (I-O) company. It has a pipeline of immune checkpoint antibodies, adoptive cell therapies and neoantigen cancer vaccines, to fight cancer. Its I-O assets include antibody-based therapeutics, monospecific and bispecific antibodies, cell therapy, vaccines and adjuvants. Its antibody candidates are Balstilimab (an anti-PD-1 antibody) and Zalifrelimab (an anti-CTLA-4 antibody), which is in Phase 2 trials as both a monotherapy...
Garo Armen Ph.D.
Chairman of the Board, Chief Executive Officer, Co-Founder
Christine Klaskin
Vice President - Finance
Address
3 Forbes Rd, 162 FIFTH AVENUE SUITE 900
New York, NY
10010
United States

Top Peers

SYMBOLLASTCHG%CHG
CHRS
Coherus BioSciences Inc
7.35-0.28-3.67%
AVIR
Atea Pharmaceuticals Inc
7.06-0.06-0.84%
MOR
MorphoSys AG
5.27+0.02+0.38%
MDXG
MiMedx Group Inc
3.48-0.13-3.60%
ICPT
Intercept Pharmaceuticals Inc
13.00-0.48-3.56%